The New England Journal of Medicine | Research & Review Articles …
WEBThe New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Cytokine Storm | New England Journal of Medicine
WEBDec 2, 2020 · Cytokine storm, a life-threatening disorder involving cytokine elevations and immune-cell hyperactivation, has various causes and is characterized by constitutional symptoms, systemic inflammation,...
The Origins of Covid-19 — Why It Matters (and Why It Doesn’t)
WEBJun 7, 2023 · Key Events in the Effort to Determine the Origins of the Covid-19 Pandemic. The joint WHO–China technical report published in March 2021 rated a zoonotic spillover as a “likely to very likely ...
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
WEBSep 11, 2014 · In this double-blind trial, we randomly assigned 8442 patients with class II, III, or IV heart failure and an ejection fraction of 40% or less to receive either LCZ696 (at a dose of 200 mg twice ...
Autoimmune Hemolytic Anemias | New England Journal of Medicine
WEBOct 6, 2021 · Autoimmune Hemolytic Anemias. Autoimmune hemolytic anemia (AIHA) is defined as increased destruction of red cells through autoimmune mechanisms, usually mediated by autoantibodies against ...
Semaglutide and Cardiovascular Outcomes in Obesity without …
WEBNov 11, 2023 · A total of 17,604 patients were enrolled; 8803 were assigned to receive semaglutide and 8801 to receive placebo. The mean (±SD) duration of exposure to semaglutide or placebo was 34.2±13.7 ...
Clinical Perspectives and Management Strategies - The New …
WEBAug 25, 2021 · Heparin is a negatively charged, sulfated glycosaminoglycan polysaccharide polymer isolated from porcine intestine, where it is stored in mast-cell granules. 4 Unfractionated heparin is a mixture ...
Dexamethasone in Hospitalized Patients with Covid-19
WEBJul 17, 2020 · A total of 2104 patients were assigned to receive dexamethasone and 4321 to receive usual care. Overall, 482 patients (22.9%) in the dexamethasone group and 1110 patients (25.7%) in the usual care ...
Lecanemab in Early Alzheimer’s Disease | NEJM
WEBNov 29, 2022 · Lecanemab reduced markers of amyloid in early Alzheimer’s disease and resulted in moderately less decline on measures of cognition and function than placebo at 18 months but was associated with ...
Randomized Trial of Three Anticonvulsant Medications for Status ...
WEBNov 27, 2019 · The Established Status Epilepticus Treatment Trial (ESETT) was an investigator-initiated, multicenter, randomized, blinded, comparative-effectiveness trial of levetiracetam, fosphenytoin, and ...
Skip to content